Eli Lilly & Co. (LLY)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.56 (+0.07%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Eli Lilly & Co. (LLY)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Key Insights

Critical company metrics and information

  • Share Price

    $826.71

  • Market Cap

    $743.47 Billion

  • Total Outstanding Shares

    949.32 Million Shares

  • Total Employees

    43,000

  • Dividend

    $1.3 Per Share Quarterly

  • IPO Date

    July 9, 1970

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    https://www.lilly.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow$988.20 Million
Net Cash Flow From Operating Activities, Continuing$6.03 Billion
Net Cash Flow From Operating Activities$6.03 Billion
Net Cash Flow From Investing Activities, Continuing$-10.31 Billion
Net Cash Flow From Investing Activities$-10.31 Billion
Net Cash Flow, Continuing$727.10 Million
Net Cash Flow From Financing Activities, Continuing$5.00 Billion
Net Cash Flow From Financing Activities$5.00 Billion
Exchange Gains/Losses$261.10 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Selling, General, and Administrative Expenses$8.09 Billion
Income/Loss From Continuing Operations Before Tax$10.15 Billion
Net Income/Loss Available To Common Stockholders, Basic$8.37 Billion
Basic Average Shares$900.88 Million
Other Operating Expenses$14.82 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income/Loss From Continuing Operations After Tax$8.37 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Cost Of Revenue$7.80 Billion
Basic Earnings Per Share$9.29
Operating Expenses$22.91 Billion
Nonoperating Income/Loss$12.50 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income Tax Expense/Benefit$1.78 Billion
Net Income/Loss Attributable To Parent$8.37 Billion
Diluted Average Shares$904.58 Million
Benefits Costs and Expenses$30.71 Billion
Diluted Earnings Per Share$9.25
Costs And Expenses$30.71 Billion
Operating Income/Loss$10.15 Billion
Net Income/Loss$8.37 Billion
Gross Profit$33.06 Billion
Revenues$40.86 Billion

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Fixed Assets$16.17 Billion
Wages$1.70 Billion
Equity$14.32 Billion
Other Current Liabilities$20.08 Billion
Other Current Assets$15.70 Billion
Liabilities$61.29 Billion
Noncurrent Liabilities$36.61 Billion
Prepaid Expenses$8.25 Billion
Current Assets$31.42 Billion
Current Liabilities$24.67 Billion
Other Non-current Assets$21.48 Billion
Assets$75.61 Billion
Equity Attributable To Parent$14.24 Billion
Accounts Payable$2.89 Billion
Inventory$7.46 Billion
Noncurrent Assets$44.19 Billion
Equity Attributable To Noncontrolling Interest$80.70 Million
Intangible Assets$6.54 Billion
Liabilities And Equity$75.61 Billion

Historical Dividends

Current dividend: $1.3 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 28, 2024Dec 10, 2024Nov 15, 2024$1.3Quarterly
Jun 24, 2024Sep 10, 2024Aug 15, 2024$1.3Quarterly
May 6, 2024Jun 10, 2024May 16, 2024$1.3Quarterly
Dec 8, 2023Mar 8, 2024Feb 15, 2024$1.3Quarterly
Nov 1, 2023Dec 8, 2023Nov 15, 2023$1.13Quarterly
Jun 26, 2023Sep 8, 2023Aug 15, 2023$1.13Quarterly
May 1, 2023Jun 9, 2023May 15, 2023$1.13Quarterly
Dec 12, 2022Mar 10, 2023Feb 15, 2023$1.13Quarterly
Oct 17, 2022Dec 9, 2022Nov 15, 2022$0.98Quarterly
Jun 27, 2022Sep 9, 2022Aug 15, 2022$0.98Quarterly
May 2, 2022Jun 10, 2022May 16, 2022$0.98Quarterly
Dec 13, 2021Mar 10, 2022Feb 15, 2022$0.98Quarterly
Oct 18, 2021Dec 10, 2021Nov 15, 2021$0.85Quarterly
Jun 29, 2021Sep 10, 2021Aug 13, 2021$0.85Quarterly
May 3, 2021Jun 10, 2021May 14, 2021$0.85Quarterly
Dec 14, 2020Mar 10, 2021Feb 12, 2021$0.85Quarterly
Oct 19, 2020Dec 10, 2020Nov 13, 2020$0.74Quarterly
Jul 15, 2020Sep 10, 2020Aug 14, 2020$0.74Quarterly
May 4, 2020Jun 10, 2020May 15, 2020$0.74Quarterly
Dec 16, 2019Mar 10, 2020Feb 14, 2020$0.74Quarterly
Oct 21, 2019Dec 10, 2019Nov 15, 2019$0.645Quarterly
Jun 19, 2019Sep 10, 2019Aug 15, 2019$0.645Quarterly
May 6, 2019Jun 10, 2019May 17, 2019$0.645Quarterly
Dec 19, 2018Mar 8, 2019Feb 15, 2019$0.645Quarterly
Oct 15, 2018Dec 10, 2018Nov 15, 2018$0.5625Quarterly
Jun 18, 2018Sep 10, 2018Aug 15, 2018$0.5625Quarterly
May 7, 2018Jun 8, 2018May 17, 2018$0.5625Quarterly
Dec 11, 2017Mar 9, 2018Feb 15, 2018$0.5625Quarterly
Oct 16, 2017Dec 8, 2017Nov 15, 2017$0.52Quarterly
Jun 19, 2017Sep 8, 2017Aug 15, 2017$0.52Quarterly
May 1, 2017Jun 9, 2017May 15, 2017$0.52Quarterly
Dec 12, 2016Mar 10, 2017Feb 15, 2017$0.52Quarterly
Oct 17, 2016Dec 9, 2016Nov 15, 2016$0.51Quarterly
Jun 20, 2016Sep 9, 2016Aug 15, 2016$0.51Quarterly
May 2, 2016Jun 10, 2016May 13, 2016$0.51Quarterly
Dec 8, 2015Mar 10, 2016Feb 12, 2016$0.51Quarterly
Oct 19, 2015Dec 10, 2015Nov 13, 2015$0.5Quarterly
May 4, 2015Jun 10, 2015May 18, 2015$0.5Quarterly
Dec 15, 2014Mar 10, 2015Feb 13, 2015$0.5Quarterly
Oct 20, 2014Dec 10, 2014Nov 14, 2014$0.49Quarterly
Jun 16, 2014Sep 10, 2014Aug 15, 2014$0.49Quarterly
May 5, 2014Jun 10, 2014May 15, 2014$0.49Quarterly
Dec 16, 2013Mar 10, 2014Feb 14, 2014$0.49Quarterly
Oct 21, 2013Dec 10, 2013Nov 15, 2013$0.49Quarterly
Jun 18, 2013Sep 10, 2013Aug 15, 2013$0.49Quarterly
May 6, 2013Jun 10, 2013May 16, 2013$0.49Quarterly
Dec 17, 2012Mar 8, 2013Feb 15, 2013$0.49Quarterly
Oct 15, 2012Dec 10, 2012Nov 15, 2012$0.49Quarterly

Related Companies

View additional S&P 500 companies similar to Eli Lilly & Co. (LLY)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.